Intranasal administration of polysulfide prevents neurodegeneration in spinal cord and rescues mice from delayed paraplegia after spinal cord ischemia

[1]  Aubry K. Miller,et al.  Hydropersulfides inhibit lipid peroxidation and ferroptosis by scavenging radicals , 2022, Nature Chemical Biology.

[2]  C. Switzer,et al.  Cysteine trisulfide oxidizes protein thiols and induces electrophilic stress in human cells , 2021, Redox biology.

[3]  Tetsuro Matsunaga,et al.  Methods in sulfide and persulfide research. , 2021, Nitric oxide : biology and chemistry.

[4]  L. Vécsei,et al.  Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid , 2021, International journal of molecular sciences.

[5]  T. Ida,et al.  High Precision Sulfur Metabolomics Innovated by a New Specific Probe for Trapping Reactive Sulfur Species. , 2020, Antioxidants & redox signaling.

[6]  T. Akaike,et al.  Enzymatic Regulation and Biological Functions of Reactive Cysteine Persulfides and Polysulfides , 2020, Biomolecules.

[7]  T. Ziv,et al.  Opposing effects of polysulfides and thioredoxin on apoptosis through caspase persulfidation , 2020, The Journal of Biological Chemistry.

[8]  H. Kimura.  Signalling by hydrogen sulfide and polysulfides via protein S‐sulfuration , 2020, British journal of pharmacology.

[9]  G. Fragoso,et al.  Intranasal Methylprednisolone Effectively Reduces Neuroinflammation in Mice With Experimental Autoimmune Encephalitis. , 2019, Journal of neuropathology and experimental neurology.

[10]  S. Rivera,et al.  Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer’s Disease Pathogenesis in a Transgenic Mouse Model , 2019, Neurotherapeutics.

[11]  T. Akaike,et al.  Enhanced Cellular Polysulfides Negatively Regulate TLR4 Signaling and Mitigate Lethal Endotoxin Shock. , 2019, Cell chemical biology.

[12]  M. Kaneki,et al.  Breathing hydrogen sulfide prevents delayed paraplegia in mice , 2019, Free radical biology & medicine.

[13]  Tetsuro Matsunaga,et al.  Polysulfide stabilization by tyrosine and hydroxyphenyl-containing derivatives that is important for a reactive sulfur metabolomics analysis , 2019, Redox biology.

[14]  T. Ida,et al.  The reaction of hydrogen sulfide with disulfides: formation of a stable trisulfide and implications for biological systems , 2018, British journal of pharmacology.

[15]  Xue Yang,et al.  Resveratrol mitigates the oxidative stress mediated by hypoxic-ischemic brain injury in neonatal rats via Nrf2/HO-1 pathway , 2018, Pharmaceutical biology.

[16]  T. Okazaki,et al.  Production of reactive persulfide species in chronic obstructive pulmonary disease , 2017, Thorax.

[17]  T. Nakazawa,et al.  Metabolomic profiling of reactive persulfides and polysulfides in the aqueous and vitreous humors , 2017, Scientific Reports.

[18]  Y. Urano,et al.  Development of a reversible fluorescent probe for reactive sulfur species, sulfane sulfur, and its biological application. , 2017, Chemical communications.

[19]  Jiashu Xie,et al.  Glutathione disulfide liposomes – A research tool for the study of glutathione disulfide associated functions and dysfunctions , 2016, Biochemistry and biophysics reports.

[20]  K. Hanaoka,et al.  Thiosulfate Mediates Cytoprotective Effects of Hydrogen Sulfide Against Neuronal Ischemia , 2015, Journal of the American Heart Association.

[21]  J. Wallace,et al.  Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter , 2015, Nature Reviews Drug Discovery.

[22]  Juhyun Song,et al.  Glutathione Suppresses Cerebral Infarct Volume and Cell Death after Ischemic Injury: Involvement of FOXO3 Inactivation and Bcl2 Expression , 2015, Oxidative medicine and cellular longevity.

[23]  H. Kimura.  Signaling molecules: hydrogen sulfide and polysulfide. , 2015, Antioxidants & redox signaling.

[24]  Wei Chen,et al.  Cytoprotective effects of hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonists are mediated by intracellular sulfane sulfur. , 2014, MedChemComm.

[25]  M. Ciriolo,et al.  Glutathione: new roles in redox signaling for an old antioxidant , 2014, Front. Pharmacol..

[26]  J. Elefteriades,et al.  Surgical management of thoracoabdominal aneurysms , 2014, Heart.

[27]  M. Suematsu,et al.  Reactive cysteine persulfides and S-polythiolation regulate oxidative stress and redox signaling , 2014, Proceedings of the National Academy of Sciences.

[28]  H. Pang,et al.  Role of hydrogen sulfide in secondary neuronal injury , 2014, Neurochemistry International.

[29]  V. Tiranti,et al.  Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model , 2013, Brain : a journal of neurology.

[30]  K. Fukunaga,et al.  Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress , 2013, Neuroscience.

[31]  J. Cleveland,et al.  Toll-Like Receptor 4–Dependent Microglial Activation Mediates Spinal Cord Ischemia–Reperfusion Injury , 2013, Circulation.

[32]  Giuseppe Perale,et al.  Current options for drug delivery to the spinal cord , 2013, Expert opinion on drug delivery.

[33]  J. Cleveland,et al.  The Evolution of Chemokine Release Supports a Bimodal Mechanism of Spinal Cord Ischemia and Reperfusion Injury , 2012, Circulation.

[34]  D. Atochin,et al.  A Novel Hydrogen Sulfide-releasing N-Methyl-d-Aspartate Receptor Antagonist Prevents Ischemic Neuronal Death* , 2012, The Journal of Biological Chemistry.

[35]  J. Cleveland,et al.  Ischemic dose-response in the spinal cord: both immediate and delayed paraplegia. , 2012, The Journal of surgical research.

[36]  J. Bavaria,et al.  Risk factors, outcomes, and clinical manifestations of spinal cord ischemia following thoracic endovascular aortic repair. , 2011, Journal of vascular surgery.

[37]  D. Atochin,et al.  Delayed Paraplegia After Spinal Cord Ischemic Injury Requires Caspase-3 Activation in Mice , 2011, Stroke.

[38]  D. Jezova,et al.  The blood–spinal cord barrier: Morphology and Clinical Implications , 2011, Annals of neurology.

[39]  D. Townsend,et al.  S-glutathionylation: from molecular mechanisms to health outcomes. , 2011, Antioxidants & redox signaling.

[40]  D. McTigue,et al.  A Mouse Model of Ischemic Spinal Cord Injury with Delayed Paralysis Caused by Aortic Cross-clamping , 2010, Anesthesiology.

[41]  M. Insko,et al.  A monobromobimane‐based assay to measure the pharmacokinetic profile of reactive sulphide species in blood , 2010, British journal of pharmacology.

[42]  Leah R. Hanson,et al.  Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease , 2008, BMC Neuroscience.

[43]  M. Luehr,et al.  Paraplegia after extensive thoracic and thoracoabdominal aortic aneurysm repair: does critical spinal cord ischemia occur postoperatively? , 2008, The Journal of thoracic and cardiovascular surgery.

[44]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[45]  Aileen J Anderson,et al.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. , 2006, Journal of neurotrauma.

[46]  R. G. Thorne,et al.  Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration , 2004, Neuroscience.

[47]  D. Giustarini,et al.  S‐Glutathionylation: from redox regulation of protein functions to human diseases , 2004, Journal of cellular and molecular medicine.

[48]  Kortaro Tanaka,et al.  Enhanced Expression of Iba1, Ionized Calcium-Binding Adapter Molecule 1, After Transient Focal Cerebral Ischemia In Rat Brain , 2001, Stroke.

[49]  R J Hinchliffe,et al.  Editor's Choice - Management of Descending Thoracic Aorta Diseases: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). , 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[50]  I. M. Vertkin,et al.  Risk Factors , 2007 .